Editorial: Minimal residual disease (MRD) assessment in multiple myeloma patients
Main Authors: | , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2023-05-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2023.1211935/full |
_version_ | 1797822284696649728 |
---|---|
author | Angelo Maiolino Angelo Maiolino Elaine Sobral Da Costa Alberto Orfao |
author_facet | Angelo Maiolino Angelo Maiolino Elaine Sobral Da Costa Alberto Orfao |
author_sort | Angelo Maiolino |
collection | DOAJ |
first_indexed | 2024-03-13T10:05:41Z |
format | Article |
id | doaj.art-b024ffe8ebb94507bd8254d7a4f46219 |
institution | Directory Open Access Journal |
issn | 2234-943X |
language | English |
last_indexed | 2024-03-13T10:05:41Z |
publishDate | 2023-05-01 |
publisher | Frontiers Media S.A. |
record_format | Article |
series | Frontiers in Oncology |
spelling | doaj.art-b024ffe8ebb94507bd8254d7a4f462192023-05-22T13:33:13ZengFrontiers Media S.A.Frontiers in Oncology2234-943X2023-05-011310.3389/fonc.2023.12119351211935Editorial: Minimal residual disease (MRD) assessment in multiple myeloma patientsAngelo Maiolino0Angelo Maiolino1Elaine Sobral Da Costa2Alberto Orfao3Department of Internal Medicine, Universidade Federal do Rio de Janeiro, Rio de Janeiro, BrazilDepartment of Hematology, Instituto Americas de Ensino, Pesquisa e Inovação, Rio de Janeiro, BrazilDepartment of Internal Medicine, Universidade Federal do Rio de Janeiro, Rio de Janeiro, BrazilTranslational and Clinical Research Program, Cancer Research Center (IBMCC, USAL-CSIC), Cytometry Service (NUCLEUS) Institute for Biomedical Research of Salamanca (IBASAL), CIBERONC and Department of Medicine, University of Salamanca, Salamanca, Spainhttps://www.frontiersin.org/articles/10.3389/fonc.2023.1211935/fullminimal residual diseasemultiple myelomaprognostic factordisease monitoringflow cytometry |
spellingShingle | Angelo Maiolino Angelo Maiolino Elaine Sobral Da Costa Alberto Orfao Editorial: Minimal residual disease (MRD) assessment in multiple myeloma patients Frontiers in Oncology minimal residual disease multiple myeloma prognostic factor disease monitoring flow cytometry |
title | Editorial: Minimal residual disease (MRD) assessment in multiple myeloma patients |
title_full | Editorial: Minimal residual disease (MRD) assessment in multiple myeloma patients |
title_fullStr | Editorial: Minimal residual disease (MRD) assessment in multiple myeloma patients |
title_full_unstemmed | Editorial: Minimal residual disease (MRD) assessment in multiple myeloma patients |
title_short | Editorial: Minimal residual disease (MRD) assessment in multiple myeloma patients |
title_sort | editorial minimal residual disease mrd assessment in multiple myeloma patients |
topic | minimal residual disease multiple myeloma prognostic factor disease monitoring flow cytometry |
url | https://www.frontiersin.org/articles/10.3389/fonc.2023.1211935/full |
work_keys_str_mv | AT angelomaiolino editorialminimalresidualdiseasemrdassessmentinmultiplemyelomapatients AT angelomaiolino editorialminimalresidualdiseasemrdassessmentinmultiplemyelomapatients AT elainesobraldacosta editorialminimalresidualdiseasemrdassessmentinmultiplemyelomapatients AT albertoorfao editorialminimalresidualdiseasemrdassessmentinmultiplemyelomapatients |